Group 1 - The core point of the article is that Sanofi Pharmaceuticals-B (02257) experienced a stock price increase of over 10%, reaching HKD 16.51 with a trading volume of HKD 5.1769 million [1] - Sanofi Pharmaceuticals-B announced plans to issue 17.3524 million subscription shares, representing approximately 14.16% of the company's enlarged issued share capital, to specific subscribers [1] - The subscription price is set at HKD 12.00 per share, which is a discount of about 19.84% compared to the closing price of HKD 14.97 on September 5 [1] Group 2 - The total amount raised from the subscription is expected to be approximately HKD 208.2 million, with a net amount of about HKD 206 million [1] - The company intends to use the proceeds from the subscription for general working capital [1]
港股异动 | 圣诺医药-B(02257)涨超10% 拟折让约19.84%发行1735.24万股认购股份 净筹约2.06亿港元